TNF-α、IL-6和VDR基因对COVID-19发生风险和病程的调节作用试点研究。

Q2 Pharmacology, Toxicology and Pharmaceutics
Liliia Fishchuk, Zoia Rossokha, Valeriy Pokhylko, Yuliia Cherniavska, Svitlana Tsvirenko, Serhii Kovtun, Nataliia Medvedieva, Viktoriia Vershyhora, Nataliia Gorovenko
{"title":"TNF-α、IL-6和VDR基因对COVID-19发生风险和病程的调节作用试点研究。","authors":"Liliia Fishchuk,&nbsp;Zoia Rossokha,&nbsp;Valeriy Pokhylko,&nbsp;Yuliia Cherniavska,&nbsp;Svitlana Tsvirenko,&nbsp;Serhii Kovtun,&nbsp;Nataliia Medvedieva,&nbsp;Viktoriia Vershyhora,&nbsp;Nataliia Gorovenko","doi":"10.1515/dmpt-2021-0127","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>COVID-19 continues to range around the world and set morbidity and mortality antirecords. Determining the role of genetic factors in the development of COVID-19 may contribute to the understanding of the pathogenetic mechanisms that lead to the development of complications and fatalities in this disease. The aim of our study was to analyze the effect of <i>TNF-α</i> (rs1800629), <i>IL-6</i> (rs1800795) and <i>VDR</i> (rs731236 and rs1544410) genes variants on the development risk and the course of COVID-19 in intensive care patients.</p><p><strong>Methods: </strong>The study group included 31 patients with diagnosis \"viral COVID-19 pneumonia\". All patients underwent standard daily repeated clinical, instrumental and laboratory examinations. Determination of <i>IL-6</i>, <i>TNF-α</i>, and <i>VDR</i> genes variants was performed using the PCR-RFLP method.</p><p><strong>Results: </strong>It was found a significant increase in the rate of the CC genotype and C allele (38.7 vs. 12.0% and 0.6 vs. 0.4%, respectively) of the <i>IL-6</i> gene in all patients of the study in comparison with population frequencies. There was a significantly higher rate of heterozygous genotypes TC and GA of the <i>VDR</i> gene in group of died patients. The rs1800629 variant of the <i>TNF-α</i> gene is associated with the need for respiratory support and its longer duration in patients with COVID-19.</p><p><strong>Conclusions: </strong>The obtained results support a hypothesis about the influence of variants of <i>IL-6</i>, <i>TNF-α</i> and <i>VDR</i> genes on severity of COVID-19. However, in order to draw definite conclusions, further multifaceted research in this area are need.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":"{\"title\":\"Modifying effects of <i>TNF-α</i>, <i>IL-6</i> and <i>VDR</i> genes on the development risk and the course of COVID-19. Pilot study.\",\"authors\":\"Liliia Fishchuk,&nbsp;Zoia Rossokha,&nbsp;Valeriy Pokhylko,&nbsp;Yuliia Cherniavska,&nbsp;Svitlana Tsvirenko,&nbsp;Serhii Kovtun,&nbsp;Nataliia Medvedieva,&nbsp;Viktoriia Vershyhora,&nbsp;Nataliia Gorovenko\",\"doi\":\"10.1515/dmpt-2021-0127\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>COVID-19 continues to range around the world and set morbidity and mortality antirecords. Determining the role of genetic factors in the development of COVID-19 may contribute to the understanding of the pathogenetic mechanisms that lead to the development of complications and fatalities in this disease. The aim of our study was to analyze the effect of <i>TNF-α</i> (rs1800629), <i>IL-6</i> (rs1800795) and <i>VDR</i> (rs731236 and rs1544410) genes variants on the development risk and the course of COVID-19 in intensive care patients.</p><p><strong>Methods: </strong>The study group included 31 patients with diagnosis \\\"viral COVID-19 pneumonia\\\". All patients underwent standard daily repeated clinical, instrumental and laboratory examinations. Determination of <i>IL-6</i>, <i>TNF-α</i>, and <i>VDR</i> genes variants was performed using the PCR-RFLP method.</p><p><strong>Results: </strong>It was found a significant increase in the rate of the CC genotype and C allele (38.7 vs. 12.0% and 0.6 vs. 0.4%, respectively) of the <i>IL-6</i> gene in all patients of the study in comparison with population frequencies. There was a significantly higher rate of heterozygous genotypes TC and GA of the <i>VDR</i> gene in group of died patients. The rs1800629 variant of the <i>TNF-α</i> gene is associated with the need for respiratory support and its longer duration in patients with COVID-19.</p><p><strong>Conclusions: </strong>The obtained results support a hypothesis about the influence of variants of <i>IL-6</i>, <i>TNF-α</i> and <i>VDR</i> genes on severity of COVID-19. However, in order to draw definite conclusions, further multifaceted research in this area are need.</p>\",\"PeriodicalId\":11332,\"journal\":{\"name\":\"Drug metabolism and personalized therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug metabolism and personalized therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/dmpt-2021-0127\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug metabolism and personalized therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/dmpt-2021-0127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 11

摘要

目标:2019冠状病毒病继续在世界各地蔓延,并创造了发病率和死亡率反记录。确定遗传因素在COVID-19发展中的作用可能有助于了解导致该疾病并发症和死亡的发病机制。本研究旨在分析TNF-α (rs1800629)、IL-6 (rs1800795)和VDR (rs731236和rs1544410)基因变异对重症监护患者COVID-19发展风险和病程的影响。方法:研究组纳入31例诊断为“病毒性COVID-19肺炎”的患者。所有患者均接受标准的每日重复临床、仪器和实验室检查。采用PCR-RFLP法检测IL-6、TNF-α和VDR基因变异。结果:与人群频率相比,研究中所有患者IL-6基因CC基因型和C等位基因的发生率显著增加(分别为38.7比12.0%和0.6比0.4%)。死亡患者组VDR基因的TC和GA基因型杂合率显著增高。TNF-α基因rs1800629变异与COVID-19患者对呼吸支持的需求及其持续时间延长有关。结论:本研究结果支持IL-6、TNF-α和VDR基因变异对COVID-19严重程度影响的假设。然而,为了得出明确的结论,需要在这一领域进一步进行多方面的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Modifying effects of TNF-α, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study.

Objectives: COVID-19 continues to range around the world and set morbidity and mortality antirecords. Determining the role of genetic factors in the development of COVID-19 may contribute to the understanding of the pathogenetic mechanisms that lead to the development of complications and fatalities in this disease. The aim of our study was to analyze the effect of TNF-α (rs1800629), IL-6 (rs1800795) and VDR (rs731236 and rs1544410) genes variants on the development risk and the course of COVID-19 in intensive care patients.

Methods: The study group included 31 patients with diagnosis "viral COVID-19 pneumonia". All patients underwent standard daily repeated clinical, instrumental and laboratory examinations. Determination of IL-6, TNF-α, and VDR genes variants was performed using the PCR-RFLP method.

Results: It was found a significant increase in the rate of the CC genotype and C allele (38.7 vs. 12.0% and 0.6 vs. 0.4%, respectively) of the IL-6 gene in all patients of the study in comparison with population frequencies. There was a significantly higher rate of heterozygous genotypes TC and GA of the VDR gene in group of died patients. The rs1800629 variant of the TNF-α gene is associated with the need for respiratory support and its longer duration in patients with COVID-19.

Conclusions: The obtained results support a hypothesis about the influence of variants of IL-6, TNF-α and VDR genes on severity of COVID-19. However, in order to draw definite conclusions, further multifaceted research in this area are need.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug metabolism and personalized therapy
Drug metabolism and personalized therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
2.30
自引率
0.00%
发文量
35
期刊介绍: Drug Metabolism and Personalized Therapy (DMPT) is a peer-reviewed journal, and is abstracted/indexed in relevant major Abstracting Services. It provides up-to-date research articles, reviews and opinion papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion. Topics: drug metabolizing enzymes, pharmacogenetics and pharmacogenomics, biochemical pharmacology, molecular pathology, clinical pharmacology, pharmacokinetics and drug-drug interactions, immunopharmacology, neuropsychopharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信